Vaccine News and Research

Latest Vaccine News and Research

Discovery of sequence-driven DNA methylation offers new path for epigenetic engineering

All the cells in an organism have the exact same genetic sequence. What differs across cell types is their epigenetics-meticulously placed chemical tags that influence which genes are expressed in each cell.

22 Nov 2025

Promising long-term vaccine for Crimean-Congo hemorrhagic fever developed

Crimean-Congo hemorrhagic fever (CCHF) is one of the world's most dangerous yet overlooked infectious diseases.

22 Nov 2025

World’s first experimental lung cancer vaccine to enter clinical trials

People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a world-first clinical trial led by researchers at UCL and the University of Oxford.

22 Nov 2025

What to know about the CDC’s baseless new guidance on autism

The rewriting of a page on the CDC's website to assert the false claim that vaccines may cause autism sparked a torrent of anger and anguish from doctors, scientists, and parents who say Health and Human Services Secretary Robert F. Kennedy Jr. is wrecking the credibility of an agency they've long relied on for unbiased scientific evidence.

22 Nov 2025

Global collaboration accelerates progress toward eliminating cervical cancer

Cervical cancer will be the first human cancer eliminated through coordinated global action. A new special issue of Cancer Biology & Medicine brings together leading experts from around the world to examine progress, challenges, and innovations in prevention, screening, and treatment.

21 Nov 2025

CAR T cell therapy could be a highly effective tool against atherosclerosis

A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer treatment-could be a highly effective tool against atherosclerosis, the condition where a build-up of plaque in the arteries reduces blood flow, leading to heart attacks and strokes.

21 Nov 2025

Global Virus Network awards first pandemic preparedness research grants across four continents

The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents.

20 Nov 2025

Study evaluates effectiveness of indoor vaccine mandates in US cities during COVID-19

Research published in Contemporary Economic Policy reveals that despite widespread adoption of indoor vaccine mandates in major US cities during the COVID-19 pandemic, there is no consistent evidence that these policies significantly increased vaccination rates or reduced COVID-19–related outcomes.

20 Nov 2025

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Rates of pertussis, also known as whooping cough, are surging in Texas, Florida, California, Oregon, and other states and localities across the country.

20 Nov 2025

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small fraction of patients.

19 Nov 2025

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis. Despite inclusion of pertussis vaccines in immunization programs since the 1970s, outbreaks have re-emerged globally due to waning immunity and bacterial evolution.

19 Nov 2025

New AI investment aims to accelerate the search for an effective HIV vaccine

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

18 Nov 2025

New model uses social media patterns to predict disease outbreaks

Vaccination rates are falling in many communities due to widespread misinformation and previously eliminated or controlled illnesses like measles are surging across the United States and Canada.

18 Nov 2025

Apriori Bio and A*STAR collaborate to develop next-generation saRNA influenza vaccines

Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.

18 Nov 2025

UNC Greensboro professor receives $3.7 million to advance research on controlling sand flies

Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.

18 Nov 2025

Gut immune cells follow an atypical pathway to provide long-lasting antiviral protection

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

17 Nov 2025

T cells drive vaccine effectiveness against porcine reproductive and respiratory syndrome virus

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies.

17 Nov 2025

Global action takes center stage on the first World Cervical Cancer Elimination Day

Today marks the first World Cervical Cancer Elimination Day – mandated by the World Health Assembly – a historic milestone in global efforts to end a preventable cancer.

17 Nov 2025

Preparing for the respiratory virus season: A guide for families

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial Virus (RSV), which can cause cold-like symptoms in most people but serious illness in infants and older adults.

17 Nov 2025

Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac

Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac". This report was published in Frontiers of Medicine, Volume 18, Issue 4, 2024.

17 Nov 2025

Vaccine News and Research

Latest Vaccine News and Research

Discovery of sequence-driven DNA methylation offers new path for epigenetic engineering

Promising long-term vaccine for Crimean-Congo hemorrhagic fever developed

World’s first experimental lung cancer vaccine to enter clinical trials

What to know about the CDC’s baseless new guidance on autism

Global collaboration accelerates progress toward eliminating cervical cancer

CAR T cell therapy could be a highly effective tool against atherosclerosis

Global Virus Network awards first pandemic preparedness research grants across four continents

Study evaluates effectiveness of indoor vaccine mandates in US cities during COVID-19

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

New AI investment aims to accelerate the search for an effective HIV vaccine

New model uses social media patterns to predict disease outbreaks

Apriori Bio and A*STAR collaborate to develop next-generation saRNA influenza vaccines

UNC Greensboro professor receives $3.7 million to advance research on controlling sand flies

Gut immune cells follow an atypical pathway to provide long-lasting antiviral protection

T cells drive vaccine effectiveness against porcine reproductive and respiratory syndrome virus

Global action takes center stage on the first World Cervical Cancer Elimination Day

Preparing for the respiratory virus season: A guide for families

Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in